4.6 Article

Cancer-associated fibroblasts in renal cell carcinoma: implication in prognosis and resistance to anti-angiogenic therapy

Journal

BJU INTERNATIONAL
Volume 129, Issue 1, Pages 80-92

Publisher

WILEY
DOI: 10.1111/bju.15506

Keywords

clear cell renal cell carcinoma; cancer-associated fibroblasts; fibroblast-associated protein; prognostic marker; anti-angiogenic treatment; resistance; #uroonc; #kcsm; #KidneyCancer

Funding

  1. Fondation de France
  2. Ligue Nationale contre le Cancer (Equipe Labellisee 2019)
  3. French National Institute for Cancer Research (INCA)
  4. Cordon de vie Foundation
  5. l'Institut National du Cancer (INCa)
  6. Government of the Principality of Monaco
  7. FX Mora Foundation

Ask authors/readers for more resources

The study found that VEGFR-TKI significantly increased the number of CAFs in tumors, which were associated with shorter disease-free and overall survival in patients. The presence of CAFs was also correlated with lymphangiogenesis and lymph node metastasis, and CAFs promoted cell migration while reducing the cytotoxic effect of VEGFR-TKI on tumor cells.
Objectives To investigate the role of cancer-associated fibroblasts (CAFs) in clear cell renal cell carcinoma (ccRCC) with respect to tumour aggressiveness, metastasis development, and resistance to anti-angiogenic therapy (vascular endothelial growth factor receptor-tyrosine kinase inhibitors [VEGFR-TKI]). Patients and Methods Our study involved tissue samples from three distinct and independent cohorts of patients with ccRCC. The presence of CAFs and tumour lymphangiogenesis was investigated, respectively, by transcriptional signatures and then correlated with tumour development and prognosis. The effect of these CAFs on tumour cell migration and VEGFR-TKI resistance was analysed on co-cultures of ccRCC cells with CAFs. Results Results from our cohorts and from in silico investigations showed that VEGFR-TKI significantly increase the number of CAFs in tumours. In the same populations of patients with ccRCC, the proportion of intra-tumoral CAFs correlated to shorter disease-free and overall survival. The presence of CAFs was also correlated with lymphangiogenesis and lymph node metastasis. CAFs increased the migration and decreased the VEGFR-TKI-dependent cytotoxic effect of tumour cells. Conclusions Our results show that VEGFR-TKI promote the development of CAFs, and CAFs favour tumour aggressiveness, metastatic dissemination, and resistance to treatment in ccRCC. CAFs could represent a new therapeutic target to fight resistance to treatment of ccRCC. Targeting CAF and immunotherapies combination are emerging as efficient treatments in many types of solid tumours. Our results highlight their relevance in ccRCC.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available